Results 301 to 310 of about 4,548,445 (364)

Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower‐Risk Myelodysplastic Syndromes (LR‐MDS) in the COMMANDS Study

American Journal of Hematology, EarlyView.
ABSTRACT The COMMANDS trial established luspatercept as a first‐line treatment for anemia in transfusion‐dependent lower‐risk (LR) myelodysplastic syndromes (MDS). Here we report red blood cell (RBC) transfusion response analysis based on somatic mutations profile and disease risk for patients treated with luspatercept or epoetin alfa in the COMMANDS ...
Rami S. Komrokji, Sheida Hayati, Manuel Ugidos, Guillermo Garcia‐Manero, Matteo Giovanni Della Porta, Amer M. Zeidan, Valeria Santini, Uwe Platzbecker, Anita K. Gandhi, Rajasekhar N. V. S. Suragani   +9 more
wiley   +1 more source

Error detection for radiotherapy planning validation based on deep learning networks. [PDF]

J Appl Clin Med Phys
Liu S, Ma J, Tang F, Liang Y, Li Y, Li Z, Wang T, Zhou M.   +7 more
europepmc   +1 more source

Factor XIII Supplementation in Postpartum Hemorrhage: From Biological Rationale to Clinical Implementation

American Journal of Hematology, EarlyView.
ABSTRACT Postpartum hemorrhage (PPH) remains the leading cause of preventable maternal mortality despite standard interventions. Recent fibrinogen trials failed to improve outcomes, prompting interest in coagulation factor XIII (FXIII). FXIII functions as “molecular cement,” cross‐linking fibrin and stabilizing clots.
Jeremy W. Jacobs, Elizabeth A. Abels, Brian D. Adkins, Garrett S. Booth, Victoria Costa, Sheharyar Raza, Michelle Simon, Jennifer S. Woo, Allison P. Wheeler   +8 more
wiley   +1 more source

Proteomic Analysis of Golden Sputum Reveals Pulmonary Complement Activation During Acute Chest Syndrome in Children With Sickle Cell Disease

American Journal of Hematology, EarlyView.
ABSTRACT Acute chest syndrome (ACS) is one of the most common severe complications of sickle cell disease (SCD). In recent years, a major role of inflammation and innate immunity has been evidenced, but ACS pathophysiology remains incompletely understood, and therapeutic options are limited.
Slimane Allali, Nabiha Sbeih, Rachel Rignault‐Bricard, Johanna Bruce, Morgane Le Gall, Claire Heilbronner, Noemie de Cacqueray, Sofia Angyalosy, Melissa Taylor, Joséphine Brice, Mariane de Montalembert, Martina Bevacqua, Emilie‐Fleur Gautier, Olivier Hermine, Thiago Trovati Maciel   +14 more
wiley   +1 more source

Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging. [PDF]

Clin Transl Radiat Oncol
Romano A, Votta C, Nardini M, Chiloiro G, Panza G, Boldrini L, Cusumano D, Galofaro E, Placidi L, Antonelli MV, Turco G, Autorino R, Gambacorta MA.   +12 more
europepmc   +1 more source

Adaptive Federated Reinforcement Learning for Optimizing Chemotherapy and Radiotherapy Plans

Garba Sani Lawal
openalex   +1 more source

Do Variations in State Consultation Programs Affect Construction Fatality Rates?

American Journal of Industrial Medicine, EarlyView.
ABSTRACT Background Along with its enforcement program, the Occupational Safety and Health Administration (OSHA) has a voluntary consultation program that responds to requests from firms to identify hazards at their workplaces. We studied the effects of this program on fatal work injuries in the construction industry.
Wayne B. Gray, John Mendeloff
wiley   +1 more source

Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer. [PDF]

Radiat Oncol
Wheeler PA, West NS, Powis R, Maggs R, Chu M, Pearson RA, Willis N, Kurec B, Reed KL, Lewis DG, Staffurth J, Spezi E, Millin AE.   +12 more
europepmc   +1 more source

Nonmetallic Carbon Fiber-Reinforced Polyetheretherketone Implants Vs Titanium Implants: Analysis of Clinical Outcomes and Influence on Postoperative Radiotherapy Planning in Metastatic Spine Tumor Surgery. [PDF]

Int J Spine Surg
Kumar N, Kumar P, Zihui GL, Seow L, Liang S, Hui SJ, Parihar R, Hallinan J, Vellayappan B, Tan JHJ.   +9 more
europepmc   +1 more source

Analysis of Patients With Monocytic and Monocytic‐Like Acute Myeloid Leukemia, Including AML‐M4 and AML‐M5, Treated With Venetoclax Plus Azacitidine

American Journal of Hematology, EarlyView.
Marina Konopleva, Courtney D. DiNardo, Yan Sun, Paul Jung, Sanam Loghavi, Jalaja Potluri, Monique Dail, Brenda Chyla, Daniel A. Pollyea   +8 more
wiley   +1 more source